Read who is Vivek Ramaswamy and why has he and Musk been appointed by Trump to lead the government efficiency department, and ...
s registration statement and other filings with the U.S. Securities and Exchange Commission.
Completed enrollment of Phase 2 BESTOW trial of tegoprubart in kidney transplantation four months ahead of schedule; on track to report topline results in fourth quarter of 2025 Announced positive ini ...
Third Quarter 2024 Financial Highlights (any comparisons are to the prior year period) Worldwide revenue of $40.3 million, representing growth of ~19% U.S. revenue of $38. ... company's other filings ...